These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 20001501)

  • 21. Loss of Bcl-2 expression in colon cancer: a prognostic factor for recurrence in stage II colon cancer.
    Poincloux L; Durando X; Seitz JF; Thivat E; Bardou VJ; Giovannini MH; Parriaux D; Barriere N; Giovannini M; Delpero JR; Monges G
    Surg Oncol; 2009 Dec; 18(4):357-65. PubMed ID: 19027288
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apoptotic and mitotic indices predict survival rates in lymph node-negative colon carcinomas.
    Sinicrope FA; Hart J; Hsu HA; Lemoine M; Michelassi F; Stephens LC
    Clin Cancer Res; 1999 Jul; 5(7):1793-804. PubMed ID: 10430084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation of Skp2 with carcinogenesis, invasion, metastasis, and prognosis in colorectal tumors.
    Li JQ; Wu F; Masaki T; Kubo A; Fujita J; Dixon DA; Beauchamp RD; Ishida T; Kuriyama S; Imaida K
    Int J Oncol; 2004 Jul; 25(1):87-95. PubMed ID: 15201993
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of cell-cycle regulators, cyclin E and p21WAF1/CIP1, potential prognostic markers for gastric cancer.
    Jang SJ; Park YW; Park MH; Lee JD; Lee YY; Jung TJ; Kim IS; Choi IY; Ki M; Choi BY; Ahn MJ
    Eur J Surg Oncol; 1999 Apr; 25(2):157-63. PubMed ID: 10218458
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
    Ioachim E
    Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determination of molecular marker expression can predict clinical outcome in colon carcinomas.
    Galizia G; Lieto E; Ferraraccio F; Orditura M; De Vita F; Castellano P; Imperatore V; Romano C; Ciardiello F; Agostini B; Pignatelli C
    Clin Cancer Res; 2004 May; 10(10):3490-9. PubMed ID: 15161706
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic significance of expressions of cell-cycle regulatory proteins in gastrointestinal stromal tumor and the relevance of the risk grade.
    Nakamura N; Yamamoto H; Yao T; Oda Y; Nishiyama K; Imamura M; Yamada T; Nawata H; Tsuneyoshi M
    Hum Pathol; 2005 Jul; 36(7):828-37. PubMed ID: 16084954
    [TBL] [Abstract][Full Text] [Related]  

  • 28. dUTP nucleotidohydrolase isoform expression in normal and neoplastic tissues: association with survival and response to 5-fluorouracil in colorectal cancer.
    Ladner RD; Lynch FJ; Groshen S; Xiong YP; Sherrod A; Caradonna SJ; Stoehlmacher J; Lenz HJ
    Cancer Res; 2000 Jul; 60(13):3493-503. PubMed ID: 10910061
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyclin E expression is a significant predictor of survival in advanced, suboptimally debulked ovarian epithelial cancers: a Gynecologic Oncology Group study.
    Farley J; Smith LM; Darcy KM; Sobel E; O'Connor D; Henderson B; Morrison LE; Birrer MJ;
    Cancer Res; 2003 Mar; 63(6):1235-41. PubMed ID: 12649182
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic implication of CDC25A and cyclin E expression on primary breast cancer patients.
    Mehdipour P; Pirouzpanah S; Sarafnejad A; Atri M; Shahrestani ST; Haidari M
    Cell Biol Int; 2009 Oct; 33(10):1050-6. PubMed ID: 19555767
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression levels of cyclin G2, but not cyclin E, correlate with gastric cancer progression.
    Choi MG; Noh JH; An JY; Hong SK; Park SB; Baik YH; Kim KM; Sohn TS; Kim S
    J Surg Res; 2009 Dec; 157(2):168-74. PubMed ID: 19559447
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic values of radiation-induced p53 in adjacent normal mucosa and p21WAF1/CIP1 expression in rectal cancer patients.
    Yoshikawa R; Yanagi H; Kusunoki M; Fujiwara Y; Noda M; Hashimoto-Tamaoki T; Yamamura T
    Int J Oncol; 2002 Dec; 21(6):1223-8. PubMed ID: 12429971
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prognostic value of cyclin E and its relation to blood vessel invasion in rectal cancer].
    Zhou YJ; Wan FL; Yao LH; Feng LY
    Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Mar; 11(2):167-71. PubMed ID: 18344087
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Expression and clinical significance of Mucin and E-cadherin in colorectal tumors].
    Yu XW; Rong W; Xu FL; Xu GY; Sun YR; Feng MY
    Ai Zheng; 2007 Nov; 26(11):1204-10. PubMed ID: 17991319
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression and gene amplification of primary (A, B1, D1, D3, and E) and secondary (C and H) cyclins in colon adenocarcinomas and correlation with patient outcome.
    Bondi J; Husdal A; Bukholm G; Nesland JM; Bakka A; Bukholm IR
    J Clin Pathol; 2005 May; 58(5):509-14. PubMed ID: 15858123
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined evaluation of expressions of cyclin E and p53 proteins as prognostic factors for patients with gastric cancer.
    Bani-Hani KE; Almasri NM; Khader YS; Sheyab FM; Karam HN
    Clin Cancer Res; 2005 Feb; 11(4):1447-53. PubMed ID: 15746045
    [TBL] [Abstract][Full Text] [Related]  

  • 37. p27 downregulation and metallothionein overexpression in gastric cancer patients are associated with a poor survival rate.
    Galizia G; Ferraraccio F; Lieto E; Orditura M; Castellano P; Imperatore V; La Manna G; Pinto M; Ciardiello F; La Mura A; De Vita F
    J Surg Oncol; 2006 Mar; 93(3):241-52. PubMed ID: 16482605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The low molecular weight cyclin E isoforms augment angiogenesis and metastasis of human melanoma cells in vivo.
    Bales E; Mills L; Milam N; McGahren-Murray M; Bandyopadhyay D; Chen D; Reed JA; Timchenko N; van den Oord JJ; Bar-Eli M; Keyomarsi K; Medrano EE
    Cancer Res; 2005 Feb; 65(3):692-7. PubMed ID: 15705861
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical significance of human telomerase reverse transcriptase in patients with colon cancer].
    Li LR; Wan DS; Pan ZZ; Hardingham J; Rieger N; Hewett P; Zhou ZW; Chen G
    Ai Zheng; 2004 Nov; 23(11 Suppl):1502-7. PubMed ID: 15566667
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Loss of KAI1 expression in the progression of colorectal cancer.
    Lombardi DP; Geradts J; Foley JF; Chiao C; Lamb PW; Barrett JC
    Cancer Res; 1999 Nov; 59(22):5724-31. PubMed ID: 10582691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.